Novita Therapeutics Launches and Closes its First Round of Financing
Novita Therapeutics, LLC, a Lenexa, Kansas biopharmaceutical and medical device company, was launched today by Nicholas Franano, M.D., and William P. Whitaker, Esq., the founders of Proteon Therapeutics, Inc.
Simultaneously, the company announced the closing of its first round of financing from angel investors.
Commenting on the funding, Whitaker said: “We are grateful to have the support of these investors and also the support of the Kansas Technology Enterprise Corporation (KTEC) which made angel tax credits available to Novita’s investors. We will work diligently to see that their confidence in this new venture is rewarded”.
Previous post: Canada, SWITCH Materials Raises C$7.5M in Series B Financing